Handesness and Life Span
NEJM 324:998, Halpern,D.F., 1991
Neuroanatomic Differences Between Dyslexic & Normal Readers on Magnetic Resonance Imaging Scans
Arch Neurol 48:410-416, Duara,R.,et al, 1991
Induction of Speech Arrest and Counting Errors with Rapid-Rate Transcranial Magnetic Stimulation
Neurol 41:697-702, Pascual-Leone,A.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 27-1991, NEJM 325:42-54991., , 1991
Idazoxan Treatment in Progressive Supranuclear Palsy
Neurol 41:986-991, Ghika,J.,et al, 1991
Positron Emission Tomography in Progressive Supranuclear Palsy
Arch Neurol 48:389-391, Bhatt,M.H.,et al, 1991
Ataxia-Telangiectasia:An Interdisciplinary Approach to Pathogenesis
Medicine 70:99-117, Gatti,R.A.,et al, 1991
Interobserver Reliability Between Neurologists in Training of Parkinson's Disease Rating Scales
Movement Disorders 6:330-335, Geminiani,G.,et al, 1991
Treatment of Parkinson's Disease with Electroconvulsive Therapy
Psychiatr Clin North Am 14:925-933, Rasmussen,K.&Abrams,R., 1991
Clozapine is Beneficial for Psychosis in Parkinson's Disease
NEurol 41:1699-1700, Kahn,N.,et al, 1991
Neurological and Neuropsychiatric Spectrum of Wilson's Disease:A Prospective Study of 45 Cases
J Neurol 238:281-287, Oder,W.,et al, 1991
Wilson's Disease
In Oxford Textbook of Clin Hepatology, Oxford Univ Press, Vol 2, Ch 20. 1, p. 947, Sternlieb,I.&Scheinberg,I.H., 1991
Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991
Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991
The Nigrostriatal Dopaminergic System Assessed in Vivo by PET Volunteers & Pts with Parkinson's Disease
Arch Neurol 47:1290-1298, Leenders,K.L.,et al, 1990
Variable Expression of Parkinson's Disease:A Base-line Analysis of the DATATOP Cohort
Neurol 40:1529-1534, Jankovic,J.,et al, 1990
Fetal Homotransplants (Ventral Mesencephalon & Adrenal Tissue) to the Striatum of Parkinsonian Subjects
Arch Neurol 47:1281-1285, Madrazo,I.,et al, 1990
Autologous Transplantation of Adrenal Medulla in Parkinson's Disease, 18-Mo Results
Arch Neurol 47:1286-1289, Olanow,C.W.,et al, 1990
The Changing Patterns of Death Rates in Parkinsonism
Neurol 40:42-49, Kurtzke,J.F.&Murphy,F.M., 1990
A Brain Transplant that Works
Lancet 335:445-446, , 1990
Medical Applications of Fetal Tissue Transplantation
Council Report, JAMA 263:565-5701990., , 1990
Adrenal Medullary Transplant to the Striatum of Patients with Advanced Parkinson's Disease
Neurol 40:273-276, Goetz,C.G.,et al, 1990
The Modern Management of Parkinson's Disease, Editorial
JNNP 53:93-95, Quinn,N., 1990
Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990
Extrapyramidal Involvement in Rett's Syndrome
Neurol 40:293-295, FitzGerald,P.M.,et al, 1990
Olivopontocerebellar Atrophy:MR Diagnosis and Relationahip to Multisystem Atrophy
Radiology 174:693-696, Savoiardo,M.,et al, 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
Ipsilateral Extinction in the Hemineglect Syndrome
Arch Neurol 47:802-804, Feinberg,T.E.,et al, 1990
Idiopathic Cerebellar Ataxia of Late Onset:Natural History and MRI Morphology
JNNP 53:297-305, Klockgether,T.,et al, 1990
Treatment of Right Hemispheric Cerebral Infarction by Hemicraniectomy
Stroke 21:874-881, Delashaw,J.B.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Neuropsychological Changes in Olivopontocerebellar Atrophy
Arch Neurol 47:997-1001, Berent,S.,et al, 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990
Striatonigral Degeneration:Clinical, MRI, & Pathologic Correlation
Neurol 40:710-711, O'Brien,C.,et al, 1990
Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990
2-Amino-3- (methylamino) -Propanoic Acid (BMAA) in Cycad Flour:An Unlikely Cause of ALS & Parkinsonism-Dementia of Guam
Neurol 40:767-772, Duncan,M.W.,et al, 1990
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Apomorphine Test to Predict Dopaminergic Responsiveness in Parkinsonian Syndromes
Lancet 336:32-34, Hughes,A.J.,et al, 1990
Two Decades of Increasing Mortality from Parkinson's Disease Among the US Elderly
Arch Neurol 47:731-734, Lilienfeld,D.E.,et al, 1990
Environmental Risk Factors in Parkinson's Disease
Neurol 40:1218-1221, Koller,W.,et al, 1990
Pyramid Sale in the Bucket Shop:DATATOP Bottoms Out
Neurol 40:1337-1339, Landau,W.M., 1990
Parkinsonism Due to a Basal Ganglia Lacunar State:Clinicopathologic Correlation
Neurol 40:897-900, Murrow,R.W.,et al, 1990
Cell Implantation in Parkinson's Disease
BMJ 301:301-302, Williams,A., 1990
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
Parkinson's Disease, Review Article
Lancet 335:948-952, Marsden,C.D., 1990
Magnetic Resonance Imaging in Parkinson's Disease
Arch Neurol 47:735-737, Huber,S.J.,et al, 1990